DrugPatentWatch Database Preview
Drugs in Development Information for BGB-3111
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug BGB-3111?
BGB-3111 is an investigational drug.
There have been 61 clinical trials for BGB-3111.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 7th 2017.
The most common disease conditions in clinical trials are Lymphoma, Carcinoma, and Neoplasms. The leading clinical trial sponsors are BeiGene, BeiGene USA, Inc., and Celgene.
There are three US patents protecting this investigational drug and twenty-seven international patents.
Summary for BGB-3111
| US Patents | 3 |
| International Patents | 27 |
| US Patent Applications | 9 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2017-11-07) |
| Vendors | 12 |
Recent Clinical Trials for BGB-3111
| Title | Sponsor | Phase |
|---|---|---|
| Long-term Extension Study of Zanubrutinib (BGB-3111) in Patients With B-cell Malignancies | BeiGene | Phase 3 |
| Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies | BeiGene | Phase 1/Phase 2 |
| A Study of Zanubrutinib (BGB-3111) in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment With Ibrutinib | BeiGene | Phase 2 |
Clinical Trial Summary for BGB-3111
Top disease conditions for BGB-3111
Top clinical trial sponsors for BGB-3111
US Patents for BGB-3111
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BGB-3111 | Start Trial | Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators | BEIGENE, LTD. (Grand Cayman, KY) | Start Trial |
| BGB-3111 | Start Trial | Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators | BeiGene, Ltd. (George Town, KY) | Start Trial |
| BGB-3111 | Start Trial | Substituted imidazo[1,2-b]pyrazoles as bruton'S tyrosine kinase modulators | BeiGene, Ltd. (Grand Cayman, KY) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BGB-3111
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BGB-3111 | Australia | 2014256633 | 2033-04-25 | Start Trial |
| BGB-3111 | Brazil | 112015025260 | 2033-04-25 | Start Trial |
| BGB-3111 | Canada | 2902686 | 2033-04-25 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
